TWI908843B - 水性組成物 - Google Patents

水性組成物

Info

Publication number
TWI908843B
TWI908843B TW110128196A TW110128196A TWI908843B TW I908843 B TWI908843 B TW I908843B TW 110128196 A TW110128196 A TW 110128196A TW 110128196 A TW110128196 A TW 110128196A TW I908843 B TWI908843 B TW I908843B
Authority
TW
Taiwan
Prior art keywords
salts
mass
remaining amount
aqueous composition
acid
Prior art date
Application number
TW110128196A
Other languages
English (en)
Chinese (zh)
Other versions
TW202220658A (zh
Inventor
久保大空
林紗衣子
喜多亜希子
Original Assignee
日商樂敦製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商樂敦製藥股份有限公司 filed Critical 日商樂敦製藥股份有限公司
Publication of TW202220658A publication Critical patent/TW202220658A/zh
Application granted granted Critical
Publication of TWI908843B publication Critical patent/TWI908843B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW110128196A 2020-07-30 2021-07-30 水性組成物 TWI908843B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020129728 2020-07-30
JPJP2020-129728 2020-07-30

Publications (2)

Publication Number Publication Date
TW202220658A TW202220658A (zh) 2022-06-01
TWI908843B true TWI908843B (zh) 2025-12-21

Family

ID=80036428

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110128196A TWI908843B (zh) 2020-07-30 2021-07-30 水性組成物

Country Status (9)

Country Link
US (1) US20230285562A1 (https=)
EP (1) EP4176882A4 (https=)
JP (1) JPWO2022025279A1 (https=)
KR (1) KR20230047400A (https=)
CN (1) CN116568285A (https=)
AU (1) AU2021318236A1 (https=)
CA (1) CA3190310A1 (https=)
TW (1) TWI908843B (https=)
WO (1) WO2022025279A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024194105A1 (en) * 2023-03-17 2024-09-26 Leo Pharma A/S A method for the treatment of chronic hand eczema in patients with moderate to severe chronic hand eczema
WO2025032221A1 (en) * 2023-08-09 2025-02-13 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Jak-inhibitor for the treatment of ten, sjs and sjs/ten overlap
EP4506005A1 (en) * 2023-08-09 2025-02-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Jak-inhibitor for the treatment of ten, sjs and sjs/ten overlap

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2018229A1 (en) * 1970-04-16 1971-10-28 Ferrous sulphate stabilized with citric acid
WO2015060208A1 (ja) * 2013-10-21 2015-04-30 日本たばこ産業株式会社 眼疾患の治療剤又は予防剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2009001884A1 (es) * 2008-10-02 2010-05-14 Incyte Holdings Corp Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
HK1251223A1 (en) 2015-07-07 2019-01-25 Japan Tobacco, Inc. Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
KR102702286B1 (ko) 2016-12-21 2024-09-04 니뽄 다바코 산교 가부시키가이샤 7H-피롤로[2,3-d]피리미딘 유도체의 제조 방법 및 그의 공결정
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물
EP4674401A3 (en) * 2019-12-27 2026-02-25 Rohto Pharmaceutical Co., Ltd Container accommodating an aqueous ophthalmic composition comprising delgocitinib
US20230285564A1 (en) * 2020-07-30 2023-09-14 Rohto Pharmaceutical Co., Ltd. Aqueous Composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2018229A1 (en) * 1970-04-16 1971-10-28 Ferrous sulphate stabilized with citric acid
WO2015060208A1 (ja) * 2013-10-21 2015-04-30 日本たばこ産業株式会社 眼疾患の治療剤又は予防剤

Also Published As

Publication number Publication date
EP4176882A1 (en) 2023-05-10
TW202220658A (zh) 2022-06-01
EP4176882A4 (en) 2024-01-10
KR20230047400A (ko) 2023-04-07
AU2021318236A1 (en) 2023-03-09
JPWO2022025279A1 (https=) 2022-02-03
US20230285562A1 (en) 2023-09-14
WO2022025279A1 (ja) 2022-02-03
CN116568285A (zh) 2023-08-08
CA3190310A1 (en) 2022-02-03

Similar Documents

Publication Publication Date Title
TWI908843B (zh) 水性組成物
TW202220659A (zh) 水性組成物
JP2018021007A (ja) アトロピン含有水性組成物
TWI880087B (zh) 用於預防或治療眼科疾病的滴眼劑組合物及其製備方法
JP2025019313A (ja) 涙液分泌促進用眼科組成物
JP2023090938A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
TWI888462B (zh) 水性組成物
HK40091389A (zh) 水性组合物
JP2021100976A (ja) 水性組成物
HK40091721A (zh) 水性组合物
JP2025011339A (ja) 摩擦低減用であるコンタクトレンズ用点眼剤、その使用方法、および装用中のコンタクトレンズの摩擦低減方法
JP6817877B2 (ja) ドルゾラミド、高分子およびホウ酸を含有する医薬組成物
WO2024010040A1 (ja) 眼科組成物
WO2024010039A1 (ja) 眼科組成物
HK40066213A (zh) 泪液分泌促进用眼科组合物
WO2024204749A1 (ja) 眼科組成物
CN112007031A (zh) 眼用制剂
JP2012224629A (ja) ペミロラストを含有する安定な水性組成物
WO2024010043A1 (ja) 眼科組成物
HK40003059B (zh) 含有阿托品的水性组合物
HK40004290A (en) Atropine-containing aqueous composition